---
title: "GeoVax Labs Signs Multiple Material Agreements"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/270536080.md"
description: "GeoVax Labs announced agreements for a public offering of 13,244,896 common units, raising approximately $2.9 million. The company signed a Placement Agency Agreement with Roth Capital Partners and a Securities Purchase Agreement with purchasers on December 19, 2025. Units priced at $0.245 include warrants exercisable at the same price, expiring in five years. Proceeds will be used for working capital and corporate purposes."
datetime: "2025-12-22T21:43:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/270536080.md)
  - [en](https://longbridge.com/en/news/270536080.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/270536080.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/270536080.md) | [繁體中文](https://longbridge.com/zh-HK/news/270536080.md)


# GeoVax Labs Signs Multiple Material Agreements

GeoVax Labs announced agreements to complete a public offering of 13,244,896 common units, each consisting of one share of common stock and common warrants to purchase two additional shares. The company signed a Placement Agency Agreement with Roth Capital Partners and a Securities Purchase Agreement with purchasers on December 19, 2025. Units priced at $0.245 raised approximately $2.9 million in net proceeds at closing on December 22, 2025. The warrants are immediately exercisable at $0.245 per share and expire five years from issuance. GeoVax intends to use the proceeds for working capital and general corporate purposes.

**Agreement 1: GeoVax Labs Signs Placement Agency Agreement With Roth Capital Partners**

-   **Agreement type**: Placement agency agreement for public offering of common units
-   **Counterparty**: Roth Capital Partners
-   **Signed / Effective**: Dec 19 2025 / same
-   **Duration / Termination**: At will
-   **Reason**: Raise capital for working capital and corporate purposes

**Agreement 2: GeoVax Labs Signs Securities Purchase Agreement With Purchasers**

-   **Agreement type**: Securities purchase agreement for public offering of common units and warrants
-   **Counterparty**: Purchasers
-   **Signed / Effective**: Dec 19 2025 / same
-   **Duration / Termination**: At will
-   **Reason**: Secure equity financing to support operations

Original SEC Filing: GeoVax Labs, Inc. \[ GOVX \] - 8-K - Dec. 22, 2025

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [GeoVax Labs, Inc. (GOVX.US)](https://longbridge.com/en/quote/GOVX.US.md)

## Related News & Research

- [Mountain Lake Updates Business Combination Agreement with Pubco](https://longbridge.com/en/news/279495943.md)
- [New Fortress Energy Signs Restructuring Support Agreement | NFE Stock News](https://longbridge.com/en/news/279468259.md)
- [Braemar Hotels Updates Compensation Framework Under Advisory Agreement](https://longbridge.com/en/news/279495940.md)
- [Callodine Capital Management LP Cuts Holdings in CVS Health Corporation $CVS](https://longbridge.com/en/news/279114368.md)
- [Key facts: Unilever mulls food split; sell Marmite, Colman’s, Bovril](https://longbridge.com/en/news/279512162.md)